al102
ayala pharmaceuticals,advaxis,novartis
['ringside', '$adxs']
$adxs updated ringside phase 2 results featured in poster discussion session at 2023 american society of clinical oncology (asco) annual meeting 
News and analysis of biomedical, biopharma, biotech, biosciences, pharmaceutical, and technology equities